Perbedaan Ciputra Development Tbk dan Diagnos Laboratorium Utama Tbk.: Ciputra Development Tbk diperdagangkan di Rp560 (kapitalisasi pasar 10,29 T, volume 24 jam 11,27 jt), sedangkan Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp224 (kapitalisasi pasar 310,75 M, volume 24 jam 963,6 rb). Perbedaan utamanya: Ciputra Development Tbk jauh lebih besar — sekitar 33,1× kapitalisasi pasar Diagnos Laboratorium Utama Tbk., dan Ciputra Development Tbk lebih aktif diperdagangkan (11,27 jt vs 963,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| CTRA | DGNS | |
|---|---|---|
Kapitalisasi Pasar | 10,29 T | 310,75 M |
Volume | 11,27 jt | 963,6 rb |
Lot | 112,75 rb | 9,64 rb |
Perputaran | 6,32 M | 217,67 jt |
Harga Rata-rata | 560,45 | 225,89 |
Nilai Transaksi | 6,32 M | 217,67 jt |
Harga Ekuilibrium Indikatif | 560 | 226 |
Volume Ekuilibrium Indikatif | 3,05 rb | 1 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Ciputra Development Tbk (the Company) was established in the Republic of Indonesia originally under the name PT Citra Habitat Indonesia based on notarial deed No. 22 dated October 22, 1981. Ciputra Developments main interest is in residential and township developments which account for approximately 90% of the companies total sales. The company has nine flagship development projects.
Selengkapnya di halaman CTRA →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Selengkapnya di halaman DGNS →